Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

Bibliographic Details
Main Authors: Javier Egea, Francisco López-Muñoz, Oscar Fernández-Capetillo, Russel J. Reiter, Alejandro Romero
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.873197/full
_version_ 1818484757189623808
author Javier Egea
Francisco López-Muñoz
Francisco López-Muñoz
Oscar Fernández-Capetillo
Oscar Fernández-Capetillo
Russel J. Reiter
Alejandro Romero
author_facet Javier Egea
Francisco López-Muñoz
Francisco López-Muñoz
Oscar Fernández-Capetillo
Oscar Fernández-Capetillo
Russel J. Reiter
Alejandro Romero
author_sort Javier Egea
collection DOAJ
first_indexed 2024-12-10T15:59:10Z
format Article
id doaj.art-addc907c3ab744d2834dc194102e74a8
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-10T15:59:10Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-addc907c3ab744d2834dc194102e74a82022-12-22T01:42:31ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-03-011310.3389/fphar.2022.873197873197Alkylating Agent-Induced Toxicity and Melatonin-Based TherapiesJavier Egea0Francisco López-Muñoz1Francisco López-Muñoz2Oscar Fernández-Capetillo3Oscar Fernández-Capetillo4Russel J. Reiter5Alejandro Romero6Molecular Neuroinflammation and Neuronal Plasticity Research Laboratory, Research Unit, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria-Hospital Universitario de La Princesa, Madrid, SpainFaculty of Health, University Camilo José Cela, Madrid, SpainNeuropsychopharmacology Unit, Hospital Doce de Octubre Research Institute (i+12), Madrid, SpainGenomic Instability Group, Spanish National Cancer Research Centre, Madrid, SpainScience for Life Laboratory, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, SwedenUTexas Health San Antonio, Long School of Medicine, San Antonio, TX, United StatesDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spainhttps://www.frontiersin.org/articles/10.3389/fphar.2022.873197/fullmelatoninalkylating agentstoxicityinflammationoxidative stressmolecular therapeutics
spellingShingle Javier Egea
Francisco López-Muñoz
Francisco López-Muñoz
Oscar Fernández-Capetillo
Oscar Fernández-Capetillo
Russel J. Reiter
Alejandro Romero
Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
Frontiers in Pharmacology
melatonin
alkylating agents
toxicity
inflammation
oxidative stress
molecular therapeutics
title Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
title_full Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
title_fullStr Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
title_full_unstemmed Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
title_short Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
title_sort alkylating agent induced toxicity and melatonin based therapies
topic melatonin
alkylating agents
toxicity
inflammation
oxidative stress
molecular therapeutics
url https://www.frontiersin.org/articles/10.3389/fphar.2022.873197/full
work_keys_str_mv AT javieregea alkylatingagentinducedtoxicityandmelatoninbasedtherapies
AT franciscolopezmunoz alkylatingagentinducedtoxicityandmelatoninbasedtherapies
AT franciscolopezmunoz alkylatingagentinducedtoxicityandmelatoninbasedtherapies
AT oscarfernandezcapetillo alkylatingagentinducedtoxicityandmelatoninbasedtherapies
AT oscarfernandezcapetillo alkylatingagentinducedtoxicityandmelatoninbasedtherapies
AT russeljreiter alkylatingagentinducedtoxicityandmelatoninbasedtherapies
AT alejandroromero alkylatingagentinducedtoxicityandmelatoninbasedtherapies